FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1849035610> ?p ?o ?g. }

• W1849035610 endingPage "4164" @default.
• W1849035610 startingPage "4153" @default.
• W1849035610 abstract "The use of cetuximab in the treatment of metastatic colorectal cancer is limited by development of resistance.We have investigated in three models of highly epidermal growth factor receptor (EGFR)-dependent colorectal cancer xenografts, the effect of maintenance therapy with different kinase inhibitors alone or in combination with cetuximab, after cytotoxic treatment induction with irinotecan plus cetuximab.SW48, LIM 1215, and GEO colorectal cancer cell lines were engrafted into nude mice and treated for 3 weeks with irinotecan and/or cetuximab. The combined treatment induced a significant reduction of tumor size. A subsequent experiment was performed in all three xenograft models in which after an induction treatment with irinotecan plus cetuximab, mice were randomly assigned to one of the following treatments: control, cetuximab, regorafenib, a selective PIK3CA inhibitor (PIK3CAi), a selective MEK inhibitor (MEKi), and/or the combination of each inhibitor with cetuximab. The cetuximab plus MEKi treatment determined the best antitumor activity with suppression of tumor growth. This effect was prolonged for 13 to 15 weeks after cessation of therapy and was accompanied by prolonged survival. Antitumor activity was accompanied by inhibition of the MAPK and MEK pathways. Moreover, in the cetuximab plus MEKi-treated SW48 xenograft group, KRAS mutations as a mechanism of acquired resistance were detected in 25% of cases compared with 75% KRAS mutations in the MEKi-treated group.A possible strategy to prevent and/or overcome resistance to anti-EGFR inhibitors in metastatic colorectal cancer is a maintenance therapy with cetuximab plus MEKi after an initial treatment with irinotecan plus cetuximab." @default.
• W1849035610 created "2016-06-24" @default.
• W1849035610 creator A5002867055 @default.
• W1849035610 creator A5003014678 @default.
• W1849035610 creator A5004016643 @default.
• W1849035610 creator A5006208754 @default.
• W1849035610 creator A5011531470 @default.
• W1849035610 creator A5012201620 @default.
• W1849035610 creator A5020655022 @default.
• W1849035610 creator A5024015438 @default.
• W1849035610 creator A5039134651 @default.
• W1849035610 creator A5040413764 @default.
• W1849035610 creator A5047539709 @default.
• W1849035610 creator A5051072215 @default.
• W1849035610 creator A5056034569 @default.
• W1849035610 creator A5076690603 @default.
• W1849035610 date "2015-09-14" @default.
• W1849035610 modified "2023-10-18" @default.
• W1849035610 title "Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models" @default.
• W1849035610 cites W1504814099 @default.
• W1849035610 cites W1968209756 @default.
• W1849035610 cites W1981804005 @default.
• W1849035610 cites W1987443121 @default.
• W1849035610 cites W1997303727 @default.
• W1849035610 cites W2005348280 @default.
• W1849035610 cites W2006168411 @default.
• W1849035610 cites W2007513598 @default.
• W1849035610 cites W2027371008 @default.
• W1849035610 cites W2041919461 @default.
• W1849035610 cites W2044468942 @default.
• W1849035610 cites W2048733292 @default.
• W1849035610 cites W2058983261 @default.
• W1849035610 cites W2062109911 @default.
• W1849035610 cites W2065920166 @default.
• W1849035610 cites W2085633477 @default.
• W1849035610 cites W2097121246 @default.
• W1849035610 cites W2100490225 @default.
• W1849035610 cites W2100589633 @default.
• W1849035610 cites W2109387929 @default.
• W1849035610 cites W2112570485 @default.
• W1849035610 cites W2116731538 @default.
• W1849035610 cites W2119746400 @default.
• W1849035610 cites W2124003148 @default.
• W1849035610 cites W2133129337 @default.
• W1849035610 cites W2134519717 @default.
• W1849035610 cites W2135118349 @default.
• W1849035610 cites W2141630197 @default.
• W1849035610 cites W2142564546 @default.
• W1849035610 cites W2143574474 @default.
• W1849035610 cites W2145854263 @default.
• W1849035610 cites W2147297736 @default.
• W1849035610 cites W2147834058 @default.
• W1849035610 cites W2150575159 @default.
• W1849035610 cites W2150625137 @default.
• W1849035610 cites W2150840254 @default.
• W1849035610 cites W2161479438 @default.
• W1849035610 cites W2162247266 @default.
• W1849035610 cites W2164837623 @default.
• W1849035610 cites W2165091551 @default.
• W1849035610 cites W2167341633 @default.
• W1849035610 cites W2171237493 @default.
• W1849035610 cites W2326149323 @default.
• W1849035610 cites W4317613976 @default.
• W1849035610 cites W4361866675 @default.
• W1849035610 doi "https://doi.org/10.1158/1078-0432.ccr-15-0211" @default.
• W1849035610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26019172" @default.
• W1849035610 hasPublicationYear "2015" @default.
• W1849035610 type Work @default.
• W1849035610 sameAs 1849035610 @default.
• W1849035610 citedByCount "16" @default.
• W1849035610 countsByYear W18490356102016 @default.
• W1849035610 countsByYear W18490356102017 @default.
• W1849035610 countsByYear W18490356102019 @default.
• W1849035610 countsByYear W18490356102020 @default.
• W1849035610 countsByYear W18490356102021 @default.
• W1849035610 countsByYear W18490356102022 @default.
• W1849035610 countsByYear W18490356102023 @default.
• W1849035610 crossrefType "journal-article" @default.
• W1849035610 hasAuthorship W1849035610A5002867055 @default.
• W1849035610 hasAuthorship W1849035610A5003014678 @default.
• W1849035610 hasAuthorship W1849035610A5004016643 @default.
• W1849035610 hasAuthorship W1849035610A5006208754 @default.
• W1849035610 hasAuthorship W1849035610A5011531470 @default.
• W1849035610 hasAuthorship W1849035610A5012201620 @default.
• W1849035610 hasAuthorship W1849035610A5020655022 @default.
• W1849035610 hasAuthorship W1849035610A5024015438 @default.
• W1849035610 hasAuthorship W1849035610A5039134651 @default.
• W1849035610 hasAuthorship W1849035610A5040413764 @default.
• W1849035610 hasAuthorship W1849035610A5047539709 @default.
• W1849035610 hasAuthorship W1849035610A5051072215 @default.
• W1849035610 hasAuthorship W1849035610A5056034569 @default.
• W1849035610 hasAuthorship W1849035610A5076690603 @default.
• W1849035610 hasConcept C121608353 @default.
• W1849035610 hasConcept C126322002 @default.
• W1849035610 hasConcept C143998085 @default.
• W1849035610 hasConcept C184235292 @default.
• W1849035610 hasConcept C2776999253 @default.
• W1849035610 hasConcept C2777506169 @default.

• next